The report contains ten-year analysis with the following sections
contact us for pricing
Check out our sample pages |
Many companies now available
Search to find companies of interest
read summary of their published patent
the company report contains more information
cadila pharmaceuticals | 211 |
novasaid | 8 |
cadilla pharmaceuticals | 2 |
cadila corporate campus | 1 |
cadila pharmaceuticals | 7 |
Title of patent family (most common patent title) |
Family members |
Filing year |
---|---|---|
poly-tlr antagonist | 21 | 2006 |
stable pharmaceutical composition for atherosclerosis | 19 | 2009 |
a pharmaceutical composition of killed cells with substantially retained immunogenicity | 16 | 2010 |
novel dipeptidyl peptidase (dp-iv) compounds | 15 | 2008 |
indole-3-carbinol derivatives | 14 | 2013 |
pharmaceutical composition for treating cancer | 14 | 2011 |
vaccine adjuvants | 12 | 2008 |
cancer antigen | 12 | 2011 |
vaccine adjuvants | 11 | 2005 |
pharmaceutical composition of taxoids | 10 | 2010 |